,uuid,title,publisher,link,providerPublishTime,type
0,e2044348-3a16-3d43-9cf7-e384ac2b536c,"Neogen's (NEOG) Q3 Earnings Miss Estimates, Margins Down",Zacks,https://finance.yahoo.com/news/neogens-neog-q3-earnings-miss-165404946.html,1648227244,STORY
1,fe0d853c-8dcc-3a99-a9ca-8af3eb25b003,Here's Why You Should Hold on to Thermo Fisher (TMO) Stock Now,Zacks,https://finance.yahoo.com/news/heres-why-hold-thermo-fisher-160804064.html,1648138084,STORY
2,9c26b66b-1065-3465-b564-04172def1c85,QIAGEN (QGEN) QuantiFeron Hits New Sales Landmark in TB Testing,Zacks,https://finance.yahoo.com/news/qiagen-qgen-quantiferon-hits-sales-141002730.html,1648131002,STORY
3,88ff7ea6-06fe-3ef5-a93d-b4c16d55f862,Henry Schein (HSIC) Stock Moves Up 16.9%: What's Driving It?,Zacks,https://finance.yahoo.com/news/henry-schein-hsic-stock-moves-125512199.html,1648040112,STORY
4,40fc0d6a-e6fd-3f29-a0db-74b374158d0d,Syneos Health (SYNH) Clinical Solutions Arm Grows Amid Cost Woe,Zacks,https://finance.yahoo.com/news/syneos-health-synh-clinical-solutions-124712652.html,1648039632,STORY
5,5e59b74b-c90e-3c64-8c1d-92174792657f,"Thermo Fisher's (TMO) New Buyouts Aid, Cost Pressure Ails",Zacks,https://finance.yahoo.com/news/thermo-fishers-tmo-buyouts-aid-162304742.html,1647966184,STORY
6,02d4d41b-df8c-37e9-97f3-6208acda1562,Myriad Genetics (MYGN) Makes Progress in Precision Oncology,Zacks,https://finance.yahoo.com/news/myriad-genetics-mygn-makes-progress-134201670.html,1647956521,STORY
7,d01b0985-b822-36ac-b4b6-f36d244c9060,Here's Why You Should Retain Abbott (ABT) Stock for Now,Zacks,https://finance.yahoo.com/news/heres-why-retain-abbott-abt-152703519.html,1647876423,STORY
